Shares of Elevance Health Inc. ELV slipped 1.42% to $405.40 Tuesday, on what proved to be an all-around great trading session ...

Elevance Health Inc. closed 27.50% below its 52-week high of $567.26, which the company achieved on September 3rd.

In a report released today, Stephen Baxter from Wells Fargo maintained a Buy rating on Elevance Health (ELV – Research Report), with a price ...

Reviewed by Caitlin Clarke Fact checked by Vikki Velasquez The Dow Jones Industrial Average, also known as the Dow or DJIA, ...

Elevance Health topped profit and revenue expectations for the fourth quarter and is guiding for more gains from premiums and products in the year ahead. The health insurer formerly known as ...

Analyst David Windley from Jefferies maintained a Buy rating on Elevance Health (ELV – Research Report) and increased the price target to ...

Investing.com -- Elevance Health Inc. reported fourth quarter earnings that missed analyst expectations, but the health insurer's shares rose following the release. The company posted adjusted ...

The calm moves in futures come after a Wednesday trading session that saw the S&P 500 set an intraday record high on Wednesday. The broad market index finished the day with a gain of 0.61%, just below ...